220 related articles for article (PubMed ID: 8246138)
21. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
Kabour A; Henegar JR; Devineni VR; Janicki JS
Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
[TBL] [Abstract][Full Text] [Related]
22. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Mackie FE; Meyer TW; Campbell DJ
Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
[TBL] [Abstract][Full Text] [Related]
23. Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: effect of chronic caffeine ingestion.
Kost CK; Li P; Pfeifer CA; Jackson EK
J Pharmacol Exp Ther; 1994 Sep; 270(3):1063-70. PubMed ID: 7932154
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with angiotensin II receptor antagonists.
Lee RJ; Brunner HR
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
[TBL] [Abstract][Full Text] [Related]
25. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
26. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
Burdmann EA; Andoh TF; Nast CC; Evan A; Connors BA; Coffman TM; Lindsley J; Bennett WM
Am J Physiol; 1995 Oct; 269(4 Pt 2):F491-9. PubMed ID: 7485533
[TBL] [Abstract][Full Text] [Related]
27. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study.
Ponchon P; Grichois ML; Elghozi JL
J Hypertens Suppl; 1993 Dec; 11(5):S244-5. PubMed ID: 8158366
[No Abstract] [Full Text] [Related]
28. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Jackson B; Franze L; Sumithran E; Johnston CI
J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
[TBL] [Abstract][Full Text] [Related]
30. Effect of chronic treatment with losartan potassium (DuP 753) on the elevation of blood pressure during chronic exposure of rats to cold.
Fregly MJ; Rossi F; Van Bergen P; Brummermann M; Cade JR
Pharmacology; 1993 Apr; 46(4):198-205. PubMed ID: 8483966
[TBL] [Abstract][Full Text] [Related]
31. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
Ziai F; Ots M; Provoost AP; Troy JL; Rennke HG; Brenner BM; Mackenzie HS
Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Lafayette RA; Mayer G; Park SK; Meyer TW
J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
34. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
[TBL] [Abstract][Full Text] [Related]
35. Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
Yo Y; Moriguchi A; Higaki J; Nagano M; Nakano N; Kamide K; Yu H; Mikami H; Ogihara T
Nephron; 1997; 76(4):466-71. PubMed ID: 9274845
[TBL] [Abstract][Full Text] [Related]
36. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
37. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
Nunez E; Hosoya K; Susic D; Frohlich ED
Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
[TBL] [Abstract][Full Text] [Related]
38. The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins.
Stier CT; Mahboubi K; DiPippo VA; Levine S; Chander PN
J Pharmacol Exp Ther; 1992 Mar; 260(3):1410-5. PubMed ID: 1545401
[TBL] [Abstract][Full Text] [Related]
39. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
40. Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
Ling Q; Guo ZG; Su Z; Guo X
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):206-10. PubMed ID: 7976371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
